共 209 条
[11]
Bray F(2010)Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis. 30 52-1558
[12]
Ferlay J(2002)Quantifying heterogeneity in a meta-analysis Stat Med. 21 1539-634
[13]
Soerjomataram I(1997)Bias in meta-analysis detected by a simple, graphical test BMJ 315 629-115
[14]
Siegel R(1989)Publication bias and dissemination of clinical research J Natl Cancer Inst. 81 107-1388
[15]
Torre L(2021)The clinical efficiency of TACE combined with simultaneous computed tomography-guided radiofrequency ablation for advanced hepatocellular carcinoma Invest New Drugs. 39 1383-928
[16]
Jemal A(2019)Prognostic impact of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation in patients with unresectable hepatocellular carcinoma: Comparison with TACE alone using decision-tree analysis after propensity score matching Hepatol Res. 49 919-1543
[17]
Erstad DJ(2019)Chemoembolization combined with radiofrequency ablation for medium-sized hepatocellular carcinoma: a propensity-score analysis J Vasc Interv Radiol. 30 1533-1583
[18]
Tanabe KK(2018)Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma Scand J Gastroenterol. 53 1575-224
[19]
Jiang C(2018)Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma Diagn Interv Radiol. 24 219-1755
[20]
Cheng G(2017)Transarterial chemoembolization monotherapy versus combined transarterial chemoembolization–microwave ablation therapy for hepatocellular carcinoma tumors≤ 5 cm: a propensity analysis at a single center Cardiovasc Intervent Radiol. 40 1748-252